This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Aurobindo Pharma Limited. Active years: 2023-2024.
Company Filing History:
Years Active: 2023-2024
Title: Prabhakaran Chakkirala: Innovator in Pharmaceutical Compositions
Introduction
Prabhakaran Chakkirala is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating neurological disorders. With a total of 2 patents to his name, he has demonstrated a commitment to advancing medical science.
Latest Patents
Chakkirala's latest patents include innovative pharmaceutical compositions. The first patent focuses on pharmaceutical compositions of deutetrabenazine, which are designed to improve stability and dissolution profiles. This invention is particularly relevant for treating chorea associated with Huntington disease and tardive dyskinesia. The second patent involves pharmaceutical compositions comprising pimavanserin, aimed at treating hallucinations and delusions associated with Parkinson's disease psychosis. This patent outlines the processes for manufacturing these compositions, showcasing his expertise in pharmaceutical development.
Career Highlights
Chakkirala is currently associated with Aurobindo Pharma Limited, a leading pharmaceutical company. His work at Aurobindo Pharma has allowed him to contribute to the development of essential medications that address critical health issues. His innovative approach and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Chakkirala has collaborated with talented professionals, including Saravanan Kannusamy and Sivakumaran Meenakshisunderam. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Prabhakaran Chakkirala's contributions to pharmaceutical compositions reflect his dedication to improving healthcare outcomes. His innovative patents and collaborative efforts highlight his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in treatments for neurological disorders.